Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

249 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study.
Grunfeld C, Kotler DP, Dobs A, Glesby M, Bhasin S. Grunfeld C, et al. Among authors: dobs a. J Acquir Immune Defic Syndr. 2006 Mar;41(3):304-14. doi: 10.1097/01.qai.0000197546.56131.40. J Acquir Immune Defic Syndr. 2006. PMID: 16540931 Clinical Trial.
Metabolic abnormalities in HIV disease and injection drug use.
Dobs A, Brown T. Dobs A, et al. J Acquir Immune Defic Syndr. 2002 Oct 1;31 Suppl 2:S70-7. doi: 10.1097/00126334-200210012-00007. J Acquir Immune Defic Syndr. 2002. PMID: 12394785 Review.
Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial.
Dobs AS, Boccia RV, Croot CC, Gabrail NY, Dalton JT, Hancock ML, Johnston MA, Steiner MS. Dobs AS, et al. Lancet Oncol. 2013 Apr;14(4):335-45. doi: 10.1016/S1470-2045(13)70055-X. Epub 2013 Mar 14. Lancet Oncol. 2013. PMID: 23499390 Free PMC article. Clinical Trial.
Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.
Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N; Testosterone Gel Study Group. Wang C, et al. Among authors: dobs a. J Clin Endocrinol Metab. 2000 Aug;85(8):2839-53. doi: 10.1210/jcem.85.8.6747. J Clin Endocrinol Metab. 2000. PMID: 10946892 Clinical Trial.
Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.
Swerdloff RS, Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Longstreth J, Berman N. Swerdloff RS, et al. Among authors: dobs a. J Clin Endocrinol Metab. 2000 Dec;85(12):4500-10. doi: 10.1210/jcem.85.12.7045. J Clin Endocrinol Metab. 2000. PMID: 11134099 Clinical Trial.
To T or not to T: Differences in Testosterone Use and Discontinuation by HIV Serostatus among Men who Have Sex with Men.
Haberlen SA, Jacobson LP, Palella FJ Jr, Dobs A, Plankey M, Lake JE, Kingsley LA, Stall R, Post WS, Brown TT. Haberlen SA, et al. Among authors: dobs a. HIV Med. 2018 Oct;19(9):634-644. doi: 10.1111/hiv.12644. Epub 2018 Jul 10. HIV Med. 2018. PMID: 29989322 Free PMC article.
Serum hormones in men with human immunodeficiency virus-associated wasting.
Dobs AS, Few WL 3rd, Blackman MR, Harman SM, Hoover DR, Graham NM. Dobs AS, et al. J Clin Endocrinol Metab. 1996 Nov;81(11):4108-12. doi: 10.1210/jcem.81.11.8923868. J Clin Endocrinol Metab. 1996. PMID: 8923868
Testosterone replacement treatment options for HIV-infected men.
Cofrancesco J Jr, Whalen JJ 3rd, Dobs AS. Cofrancesco J Jr, et al. Among authors: dobs as. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 1;16(4):254-65. doi: 10.1097/00042560-199712010-00006. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9402072 Review.
The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection.
Dobs AS, Cofrancesco J, Nolten WE, Danoff A, Anderson R, Hamilton CD, Feinberg J, Seekins D, Yangco B, Rhame F. Dobs AS, et al. Am J Med. 1999 Aug;107(2):126-32. doi: 10.1016/s0002-9343(99)00193-x. Am J Med. 1999. PMID: 10460042 Clinical Trial.
Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men.
Ketlogetswe KS, McKibben R, Jacobson LP, Li X, Dobs AS, Budoff M, Witt MD, Palella FJ Jr, Kingsley L, Margolick JB, Post WS, Brown TT. Ketlogetswe KS, et al. J Acquir Immune Defic Syndr. 2015 Dec 1;70(4):362-9. doi: 10.1097/QAI.0000000000000725. J Acquir Immune Defic Syndr. 2015. PMID: 26090754 Free PMC article.
249 results
Jump to page
Feedback